Differences between co-users of cocaine and crack among Canadian illicit opioid users

Sucht

Volumn 51, Issue 4 SPEC. ISS., 2005, Pages 217-224

  Fischer, Benedikt ^a,b   Monga, Neerav ^a,c   Manzoni, Patrik ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Ontario Familial Colon Cancer Registry ^*  (Canada)

Author keywords

Canada; Cocaine; Crack; Opioids; Polydrug use

Indexed keywords

ILLICIT DRUG;

ADULT; ARTICLE; CANADA; COCAINE DEPENDENCE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DRUG ABUSE; FEMALE; HUMAN; MALE; OPIATE ADDICTION; PREVALENCE; RISK FACTOR; SOCIOECONOMICS;

EID: 24044439504     PISSN: 09395911     EISSN: None     Source Type: Journal    
DOI: 10.1463/2005.04.04     Document Type: Article

References (60)

1. Best, D., Harris, J., Gossop, M., Farrell, M., Finch, E., Noble, A. et al. (2000). Use of non-prescribed methadone and other illicit drugs during methadone maintenance treatment. Drug and Alcohol Review, 19, 9-16.
2. Booth, R. E., Kwiatkowski, C. F., & Chitwood, D. D. (2000). Sex related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug & Alcohol Dependence, 58, 219-226.
3. Bourgois, P. (1995). In search of respect: selling crack in El Barrio. New York: Cambridge University Press.
4. Bourgois, P. & Bruneau, J. (2000). Needle exchange, HIV infection, and the politics of science: Confronting Canada's cocaine injection epidemic with participant observation. Medical Anthropology, 18, 325-350.
5. Bourgois, P. & Dunlap, E. (1993). Exercising sex-for-crack: an ethnographic perspective from Harlem. In M.S. Ratner (Ed.), Crack pipe as pimp: an ethnographic investigation of sex-for-crack exchanges (pp. 97-132). New York: Lexington Books.
6. Brady, K. T. & Malcolm, R. J. (2004). Substance use disorders and co-occurring axis I psychiatric disorders. In M. Galanter & H. D. Kleber (Eds.), Textbook of substance abuse treatment (pp. 529-538). Washington, DC: American Psychiatric Publishing.
7. CCENDU (2003). 2002 National Report: Drug Trends and the CCENDU Network Ottawa: Canadian Centre on Substance Abuse.
8. Charney, D. A., Paraherakis, A. M., & Gill, K. J. (2001). Integrated treatment of comordid depression and substance use disorders. Journal of Clinical Psychiatry, 62, 672-677.
9. Cherubin, C. E. & Sapira, J. D. (1993). The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Annals of Internal Medicine, 119, 1017-1028.
10. Coffin, P., Galea, S., Ahern, J., Leon, A., Vlahov, D., & Tardiff, K. (2003). Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. Addiction, 98, 739-747.
11. Cornish, J. & O'Brien, C. (1996). Crack cocaine abuse: an epidemic with many public health consequences. Annual Review of Public Health, 17, 259-273.
12. Darke, S. & Hall, W. (2003). Heroin overdose: research and evidence-based intervention. Journal of Urban Health, 80, 189-200.
13. Erickson, P. G., Butters, J., McGillicuddy, P., & Hallgren, A. (2000). Crack and prostitution: gender, myths, and experiences. Journal of Drug Issues, 30, 767-788.
14. Federal/Provincial/Territorial Committee on Injection Drug Use (2001). Reducing the harm associated with injecting drug use in Canada. Ottawa: Health Canada.
15. Fischer, B., Brissette, S., Brochu, S., Bruneau, J., el-Guebaly, N., Noël, L., Rehm, J., Tyndall, M. Cameron, W., Mun, P., Haydon, E. & Baliunas, D et al. (2004). Prevalence and determinants of overdose incidents among illicit opioid users in five cities across Canada. Canadian Medical Association Journal, 171, 235-239.
16. Fischer, B., Kirst, M., Rehm, J., Marsh, D., Bondy, S., & Tyndall, M. (2000a). The phenomenon of so-called »other drug use« among opiate addicts in the North American context: Evidence, consequences, questions. In B. Westermann, G. Bellman, & C. Jellinek (Eds.), Beigebrauch: Offene Grenzen der Substitution (pp. 95-118). Weinheim: BELTZ Deutscher Studien Verlag.
17. Fischer, B., Rehm, J., & Blitz-Miller, T. (2000b). Injection drug use and preventive measures: a comparison of Canadian and Western European jurisdictions over time. Canadian Medical Association Journal, 162, 1709-1713.
18. Fischer, B., Rehm, J., Brissette, S., Brochu, S., Bruneau, J., el-Guebaly, N., Noel, L., Tyndall, M., Wild, C., Mun, P. & Baliunas, D. (2005a). Illicit opioid users in Canada: Comparing social, health and drug use characteristics of untreated users in five cities (OPICAN study). Journal of Urban Health, 82, 250-266.
19. Fischer, B., Rehm, J., Kim, G., & Kirst, M. (2005b). Eyes wide shut? A conceptual and empirical critique of methadone maintenance treatment. European Addiction Research, 11, 1-12.
20. Frei, A. & Rehm, J. (2002). Die Prävalenz psychischer Komorbidität unter Opiatabhängigen: eine Metaanalyse bisheriger Studien. Psychiatrische Praxis, 29, 258-262.
21. Giddings, D., Christo, G., & Davy, J. (2003). Reasons for Injecting and Not Injecting: a qualitative study to inform therapeutic intervention. Drugs, Education, Prevention and Policy, 10, 95-104.
22. Grella, C., Anglin, M., Wugalter, S., Rawson, R., & Hasson, A. (1994). Reasons for discharge from methadone maintenance for addicts at high risk of HIV infection or transmission. Journal of Psychoactive Drugs, 26, 223-232.
23. Grella, C., Anglin, M., & Wugalter, S. (1997). Patterns and predictors of cocaine and crack use by clients in standard and enhanced methadone maintenance treatment. American Journal of Drug and Alcohol Abuse, 23, 15-42.
24. Hankins, C. (1998). Syringe exchange in Canada: Good but not enough to stem the HIV tide. Substance Use & Misuse, 33, 1129-1145.
25. Harrison, L. (1995). The validity of self-reported data on drug use. The Journal of Drug Issues, 25, 91-111.
26. Haydon, E. & Fischer, B. (2005a). Crack use as a public health problem in Canada - Call for an evaluation of »safer crack use kits«. Canadian Journal of Public Health, 96, 185-188.
27. Haydon, E., Chorny, Y., & Fischer, B. (2005b). Crack use and public health (with specific focus on hepatitis C): Epidemiology, risk factors and interventions (final draft report). Ottawa: Public Health Agency for Canada.
28. Hunt, D., Strug, D., Goldsmith, D., Lipton, D., Spunt, B., Truitt, L. et al. (1984). An instant shot of »aah«: Cocaine use among methadone clients. Journal of Psychoactive Drugs, 16, 217-227.
29. Hunter, G., Donoghoe, M., & Stimson, G. (1995). Crack use and injection on the increase among injecting drug users in London. Addiction, 90, 1397-1400.
30. I-Track (2004). I-Track: Enhanced Surveillance of Risk Behaviours among Injecting Drug Users in Canada (Pilot Survey Report). Ottawa: Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Population and Public Health Branch, Health Canada.
31. Inciardi, J. A. (1995). Crack, crack house sex, and HIV risk. Archives of Sexual Behavior, 24, 249-269.
32. Inciardi, J. A. (1993). The Miami sex-for-crack market. In M.S. Ratner (Ed.), Crack pipe as pimp: an ethnographic investigation of sex-for-crack exchanges (pp. 36-68). New York: Lexington Books.
33. Inciardi, J. A. & Surratt, H. L. (2001). Drug use, street crime, and sex-trading among cocaine-dependent women: Implications for public health and criminal justice policy. Journal of Psychoactive Drugs, 33, 379-389.
34. Johnson, B. D., Natarajan, M., Dunlap, E., & Elmoghazy, E. (1994). Crack abusers and noncrack abusers - Profiles of drug-use, drug sales and nondrug criminality. Journal of Drug Issues, 24, 117-141.
35. Kemmesies, U. (1997). Compulsive drug users in the Netherlands and Germany: The open drug scenes in Amsterdam and Frankfurt am Main. International Journal of Drug Policy, 8, 187-200.
36. Kerr, T., Tyndall, M., Li, K., Montaner, J. S. G., & Wood, E. (2005). Safer injection facility use and syringe sharing in injection drug users. The Lancet, early online publication, March 18 2005.
37. Khantzian, E. (1997). The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harvard Review of Psychiatry, 4, 231-224.
38. Krausz, M., Degkwitz, P., Kuhne, A., & Verthein, U. (1998). Comorbidity of opiate dependence and mental disorders. Addictive Behaviors, 23, 767-783.
39. Leri, F., Bruneau, J., & Stewart, J. (2003). Understanding polydrug use: Reviewing heroin and cocaine co-use. Addiction, 98, 7-22.
40. Leri, F., Stewart, J., Tremblay, A., & Bruneau, J. (2004). Heroin and cocaine co-use in a group of injection drug users in Montreal. Journal of Psychiatry and Neuroscience, 29, 40-47.
41. Logan, T. K. & Leukefeld, C. (2000). Sexual and drug use behaviors among female crack users: A multi-site sample. Drug and Alcohol Dependence, 58, 237-245.
42. McBride, A., Pates, R. M., Arnold, K., & Ball, N. (2001). Needle fixation, the drug user's perspective: a qualitative study. Addiction, 96, 1049-1058.
43. Monga, N., Rehm, J., Fischer, B., Brissette, S., Bruneau, J., el-Guebaly, N. et al. (2005). Using latent class analysis (LCA) to analyze patterns of drug use in a population of illicit opioid users. (unpublished data).
44. O'Driscoll, P., McGough, J., Hagan, H., Thiede, H., Critchlow, C., & Alexander, E. (2001). Predictors of accidental fatal drug overdose among a cohort of injection drug users. American Journal of Public Health, 91, 984-987.
45. Palepu, A., Strathdee, S. A., Hogg, R. S., Anis, A. H., Rae, S., Cornelisse, P. G. A. et al. (1999). The social determinants of emergency department and hospital use by injection drug users in Canada. Journal of Urban Health, 76, 409-418.
46. Patrick, D. M., Strathdee, S. A., Archibald, C. P., Ofner, M., Craib, K. J. P., Cornelisse, P. G. A. et al. (1997). Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. International Journal of STD & AIDS, 8, 437-445.
47. Patrick, D., Tyndall, M., Cornelisse, P., Li, K., Sherlock, C, Rekart, M. et al. (2001). Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. Canadian Medical Association Journal, 165, 889-895.
48. Remis, R., Leclerc, P., Routledge, R., Taylor, C., Bruneau, J., Beauchemin, J. et al. (1998). Consortium to characterize injection drug users in Canada (Montreal, Toronto and Vancouver) (Final report). Toronto.
49. Roy, E., Haley, N., Leclerc, P., Boivin, J.-F., Cedras, L., & Vincelette, J. (2001). Risk factors for Hepatitis C virus infection among street youths. Canadian Medical Association Journal, 165, 557-560.
50. Spittal, P., Bruneau, J., Craib, K., Miller, C., Lamothe, F., Weber, A. et al. (2003). Surviving the sex trade: A comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs. Aids Care, 15, 187-195.
51. Strathdee, S., Patrick, D., Archibald, C. P., Ofner, M., Cornelisse, P., Rekart, M. et al. (1997a). Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addiction, 92, 1339-1347.
52. Strathdee, S., Patrick, D., Currie, S., Cornelisse, P., Rekart, M., Montaner, J. et al. (1997b). Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS, 11, F59-F65.
53. Strike, C., Urbanoski, K., Fischer, B., Marsh, D., & Millson, P. (in press). Increases in methadone maintenance treatment in Ontario, 1996-2001. Journal of Substance Abuse Treatment.
54. Thorpe, L. E., Quellet, L. J., Levy, J. R., Williams, I. T., & Monterroso, E. R. (2000). Hepatitis C virus infection: Prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. Journal of Infectious Diseases, 182, 1588-1594.
55. Tortu, S., McMahon, J., Pouget, E., & Hamid, R. (2004). Sharing of noninjection drug-use implements as a risk factor for hepatitis C. Substance Use and Misuse, 39, 211-224.
56. Verthein, U., Haasen, C., Prinzleve, M., Degkwitz, P., & Krausz, M. (2001). Cocaine use and the utilisation of drug help service by consumers of the open drug scene in Hamburg. European Addiction Research, 7, 176-183.
57. Villano, C., Rosenblum, A., Magura, S., & Fong, C. (2002). Improving treatment engagement and outsomes for cocaine-using methadone patients. American Journal of Drug and Alcohol Abuse, 28, 213-230.
58. Wall, R., Rehm, J., Fischer, B., Brands, B., Gliksman, L., Stewart, J. et al. (2001). The social cost of untreated opiate use. Journal of Urban Health, 77, 688-722.
59. Weinstock, H. S., Bolan, G., Reingold, A. L., & Polish, L. B. (1993). Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases. Journal of the American Medical Association, 269, 392-394.
60. Williams, T. (1992). Crackhouse: Notes from the end of the line. Reading, Mass.: Addison-Wesley Publishing.